Home/Pipeline/Undisclosed Vaccine Program(s)

Undisclosed Vaccine Program(s)

Infectious Disease

Pre-clinicalActive

Key Facts

Indication

Infectious Disease

Phase

Pre-clinical

Status

Active

Company

Brazos Biomedical

About Brazos Biomedical

Brazos Biomedical is an early-stage, private biotech firm targeting infectious diseases with a novel vaccine and therapeutic platform. Founded in 2020, the company is in the pre-clinical research and development phase, building its pipeline and technology foundation. Its strategic location in Houston provides access to a major biomedical research hub. As a pre-revenue entity, its near-term focus is on advancing its platform and securing partnerships or funding to transition programs into clinical development.

View full company profile

Therapeutic Areas

Infectious Disease

Other Infectious Disease Drugs

Drug	Company	Phase	Status
Vaccine Platform	Biolingus	Research	Active
Pipeline Antibiotics	BioQ Pharma	Unknown	Active
Antivirals Platform	Qubit Pharmaceuticals	Discovery	Active
Antibiotic Development Program	AF ChemPharm	Pre-clinical	Active
Prophylactic Vaccine Development	ImmuneSpec	Service	Active
Optimized VHH vs. SARS-CoV-2	Ordaos Bio	Pre-clinical	Active
AmorphOX Vaccine	Orexo	Preclinical	Active (with Abera)
Undisclosed Asset 1	Uvax Bio	Research	Active
Undisclosed Asset 2	Uvax Bio	Research	Active
Undisclosed Asset 3	Uvax Bio	Research	Active
Vaccine Immune Response (SARS-CoV-2)	CellChorus	Preclinical	Active
POCKIT™ Central COVID-19 Assay	GeneReach Biotechnology	commercial	Active